Physical therapy practices typically sell for 2.0x–3.0x seller's discretionary earnings (SDE) or 5x–7x EBITDA. The higher EBITDA multiple reflects the growing consolidation in physical therapy driven by strategic acquirers and private equity firms who recognize the scalability and recurring revenue potential of well-managed practices with established referral networks. Understanding PT valuation drivers helps you position your practice for optimal exit economics and identify improvement opportunities that matter to acquirers.

The primary driver is visit volume and visits-per-therapist productivity. Buyers examine raw patient visits monthly — whether you're doing 500, 2,000, or 5,000 visits — because visits directly generate billable therapy revenue. More critically, they measure visits per licensed physical therapist, which reveals operational efficiency and margin potential. A practice generating 25 patient visits per therapist weekly demonstrates superior leverage compared to one achieving 15 visits per therapist. This productivity gap translates directly into EBITDA-conversion differences of 15–25 percentage points, materially affecting final valuation.

Referral source quality and diversification dramatically affect valuations. PT practices heavily dependent on one orthopedic surgeon or hospital system face concentration risk that depresses multiples significantly. Buyers strongly prefer practices with referral relationships distributed across multiple orthopedic surgeons, primary care physicians, sports medicine specialists, and direct-access patients self-referring without physician referral. Direct-access states allow patients to visit PT without a doctor referral, expanding your addressable market and demonstrating less reliance on specific referral partners.

Payer contract quality matters because it determines reimbursement rates, payment terms, and overall cash flow timing. Practices with strong commercial insurance contracts, proper Medicare credentialing, and relationships with multiple health systems command valuations significantly higher than single-payer-dependent practices. Document your payer mix, average reimbursement rate per visit, and denial rates.

Geographic diversification through multiple practice locations amplifies value. A single-location practice with $1.2M EBITDA might sell for a 5x multiple, while a multi-location chain with equivalent per-location performance might justify 6x–7x multiples because buyers see repeatable growth potential and proven systems. Document each location's performance, your operational playbook, and your hiring and onboarding systems.

Clinical outcomes documentation and patient satisfaction metrics strengthen buyer confidence. Practices demonstrating strong functional outcome tracking (using FOTO, ROMS, or similar measurement platforms), patient satisfaction scores above the 90th percentile, and documented evidence-based clinical protocols command premium valuations because their clinical model is defensible to acquirers and payers.

Therapist retention is a closely-watched operational metric. PT licensing creates regional supply constraints, and practices with sub-15% annual therapist turnover demonstrate strong culture, competitive compensation, and career-pathing. Document tenure by therapist, your continuing-education investment, and your clinical-mentorship structure.

Specific buyer types approach PT acquisitions differently. Strategic acquirers include large healthcare systems acquiring PT services to keep patients within their networks. National PT chains — Hanger, ATI Physical Therapy, Athletico, Select Medical, Concentra — actively consolidate regional practices to build scale. Private equity platforms have entered PT aggressively (Audax, Lindsay Goldberg, Cressey & Company), recognizing recurring revenue characteristics, scale economics, and favorable long-term reimbursement trends. Traditional healthcare acquirers view PT as complementary to orthopedic surgery and sports medicine within integrated delivery systems.

To maximize practice valuation, track total monthly patient visits, visits per licensed PT and assistant, total billable hours per clinician, referral source breakdown by volume and payer mix, direct-access patient percentage, payer reimbursement rates, denial rates, patient retention and readmission rates, and staff turnover. Demonstrate consistent performance against industry benchmarks. Build systems that reduce reliance on owner clinical time.

Practical 18-month playbook to lift your multiple. Months 1-3: pull your operational scorecard — visits-per-PT-per-week, referral-source breakdown by volume, payer mix and denial rates, direct-access percentage, therapist tenure, and clinical-outcome scores. Months 4-9: improve clinician productivity through scheduling optimization, technician leverage, and same-day-evaluation protocols to push visits-per-PT toward 25 weekly. Months 6-12: diversify referral sources by building relationships with primary care, sports medicine, and direct-access patient acquisition channels. Months 9-15: implement outcome tracking (FOTO, ROMS, or similar) and start sharing data with payers and referrers. Months 12-18: stabilize therapist retention with competitive comp, mentorship structures, and CEU investment. Months 15-18: assemble three-year financials, visit and outcome history, payer-mix detail, and therapist-tenure reports for diligence. Done well, this playbook moves a $3M-revenue practice from a 5x EBITDA offer to 6.5x — adding $700K-$1.4M of enterprise value at exit. Adjacent valuation models include chiropractic, pain management, and medical practice operations. PT practices building cash-pay revenue lines — performance training, wellness, post-rehab fitness, dry needling, manual therapy programs — diversify revenue away from insurance reimbursement and command premium multiples because cash-pay margins are structurally higher.